In addition, MDMs from healthy controls treated with a CFTR inhibitor (CFTRInh-172) were incapable of polarizing into anti-inflammatory M2 macrophages, suggesting that understanding the link between CFTR dysfunction and M2 polarization may provide new therapeutic targets for CF (62). Here, CFTR is linked to cystic fibrosis.